Phase 1b/2 Study of IV Sarilumab in Adult With RA

Recruiting

Phase 1

Phase 2

Sarilumab with csDMARDsPhase 1b/2 Study of IV Sarilumab in Adult With RA

Sponsor:

Sanofi

Code:

NCT07704580

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sarilumab, SAR153191 SC

Sarilumab, SAR153191 IV

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-20. This information was provided to ClinicalTrials.gov by Sanofi on 2026-07-15.